With increased incidences of reimbursement rejections by payers and a growing usage of pricing and reimbursement tools market access is becoming increasingly restricted…

1. PARIOFORMA
With increased incidences of reimbursement rejections by payers and a
growing usage of pricing and reimbursement tools market access is becoming
increasingly restricted…
 In many markets, the process for gaining reimbursement is characterized by a health technology assessment (HTA)
approach whereby payer organizations evaluate new medical technologies on the basis of their clinical value, cost-
effectiveness and other health economic factors.
 Consequently, manufacturers of
pharma products now face
unique informational and
evidentiary demands to
demonstrate comparative
value.
 Of all factors contributing to
product success, payer access is
considered the most critical –
therefore, the sooner this is at
the table, the more likely
successful pricing and
reimbursement strategies are to
be realized.
Parioforma Ltd – 55 Princes Gate – London SW7 2PN – United Kingdom
www.parioforma.com

2. Case Study:
A global pharmaceutical manufacturer contacted us to undertake an early environment
mapping exercise in selected emerging markets – with particular focus on evolving HTA PARIOFORMA
requirements
Key findings:
 Changing decision-makers – physician power is eroding.
 Multiple buyers – all with different priorities and differing views about your product, adding complexity to the
purchasing process.
 Rise of new influencers – payer
organisations and health
technology assessment agencies
are becoming gatekeepers.
 Pricing pressure – intense
pressure to contain costs and
work within pre-defined
budgets.
 Stakeholder fragmentation – a
broadened range of market
access stakeholders.
 Emerging markets are complex
and evolving environments –
political and economic transition
has resulted in many changes in
the healthcare environment of
these countries.
Abbreviations:
CEA – Cost Effectiveness Analysis; CUA – Cost Utility Analysis; BIA – Budget Impact Analysis
Parioforma Ltd – 55 Princes Gate – London SW7 2PN – United Kingdom
www.parioforma.com

3. Plan ahead and start early in the product lifecycle:
 Every market is different – payer profiling & environment mapping is key to helping manufacturers
understand the complex reimbursement, coverage and decision making landscape. PARIOFORMA
 Studies need not be in-depth, early directional work can guide strategy development, help build
early value messages and save time and money by ensuring that any future large global study asks
the right questions and is not overly complicated.
We can help you:
We specialise in payer research and environment mapping - quickly and affordably. With a network of
over 500 payer specialists worldwide - our scope is global and we have the resources and experience
to tailor our services to meet your needs…
For further information, or to discuss your Payer & Market Access
requirements, contact us now on +44 (0) 207 225 3538 or email Charles
Rowlands at: charles.rowlands@parioforma.com